The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A biomarker panel for acute graft-versus-host disease
Open accessAbstract
No validated biomarkers exist for acute graft-versus-host disease (GVHD). We screened plasma with antibody microarrays for 120 proteins in a discovery set of 42 patients who underwent transplantation that revealed 8 potential biomarkers for diagnostic of GVHD. We then measured by enzyme-linked immunosorbent assay (ELISA) the levels of these biomarkers in samples from 424 patients who underwent transplantation randomly divided into training (n = 282) and validation (n = 142) sets. Logistic regression analysis of these 8 proteins determined a composite biomarker panel of 4 proteins (interleukin-2-receptor-alpha, tumor-necrosis-factor-receptor-1, interleukin-8, and hepatocyte growth factor) that optimally discriminated patients with and without GVHD. The area under the receiver operating characteristic curve distinguishing these 2 groups in the training set was 0.91 (95% confidence interval, 0.87–0.94) and 0.86 (95% confidence interval, 0.79–0.92) in the validation set. In patients with GVHD, Cox regression analysis revealed that the biomarker panel predicted survival independently of GVHD severity. A panel of 4 biomarkers can confirm the diagnosis of GVHD in patients at onset of clinical symptoms of GVHD and provide prognostic information independent of GVHD severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Cited by
Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.05.003 · Cited by 436
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
Vander Lugt, M. T., Braun, T. M., Hanash, S., Ritz, J., Ho, V. T., Antin, J. H., Zhang, Q., Wong, C.-H., Wang, H., Chin, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213299 · Cited by 405
Self-citationMesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01855-9 · Cited by 343
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
Ferrara, J. L. M., Harris, A. C., Greenson, J. K., Braun, T. M., Holler, E., Teshima, T., Levine, J. E., Choi, S. W. J., Huber, E., Landfried, K., et al. (2011) · Blood · doi:10.1182/blood-2011-08-375006 · Cited by 339
Self-citationA prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
Levine, J. E., Braun, T. M., Harris, A. C., Holler, E., Taylor, A., Miller, H., Magenau, J., Weisdorf, D. J., Ho, V. T., Bolaños-Meade, J., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(14)00035-0 · Cited by 309
Self-citation
Metadata
- Authors
- Paczesny, S., Krijanovski, O. I., Braun, T. M., Choi, S. W., Clouthier, S. G., Kuick, R., Misek, D. E., Cooke, K. R., Kitko, C. L., Weyand, A., Bickley, D., Jones, D., Whitfield, J., Reddy, P., Levine, J. E., Hanash, S. M., & Ferrara, J. L. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-01-08
- Volume
- 113
- Issue
- 2
- Pages
- 273-278
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2170334907
- Cited by
- 407
- References
- 1
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A biomarker panel for acute graft-versus-host disease. https://app.cochat.ai/papers/10.1182/blood-2008-07-167098
- The paper
- Paczesny, S., Krijanovski, O. I., Braun, T. M., Choi, S. W., Clouthier, S. G., Kuick, R., Misek, D. E., Cooke, K. R., Kitko, C. L., Weyand, A., Bickley, D., Jones, D., Whitfield, J., Reddy, P., Levine, J. E., Hanash, S. M., & Ferrara, J. L. M. (2009). A biomarker panel for acute graft-versus-host disease. Blood. https://doi.org/10.1182/blood-2008-07-167098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.